Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

An Open-Label, Randomized Naturalistic Study to Evaluate the Incidence of Hypoglycemia Comparing Sitagliptin With Sulfonylurea Treatment in Patients With Type 2 Diabetes During Ramadan Fasting

This study will examine whether the incidence of hypoglycemia in patients fasting for Ramadan is lower when treated with sitagliptin as compared to sulfonylurea treatment.

This study and NCT01340768 (MK-0431-262) have the same design but are conducted under separate protocols, in different countries, according to local guidelines.

Inclusion Criteria:

• Muslim men and women with type 2 diabetes
• Participants who intend to fast during the month of Ramadan
• Participants who have been on a stable dose of sulfonylurea for at least three months

Exclusion Criteria:

• Participants with type 1 diabetes mellitus
• Pregnant or breast feeding women
• Participants with hypersensitivity or contraindication to dipeptidyl peptidase (DPP-4) treatment
• Participants on insulin
• Participants on any class of oral diabetic therapy other than sulfonylurea or metformin